Optimization of a Dihydropyrrolopyrazole Series of Transforming Growth Factor-β Type I Receptor Kinase Domain Inhibitors: Discovery of an Orally Bioavailable Transforming Growth Factor-β Receptor Type I Inhibitor as Antitumor Agent
Li, Hong-yu, McMillen, William T., Heap, Charles R., McCann, Denis J., Yan, Lei, Campbell, Robert M., Mundla, Sreenivasa R., King, Chi-Hsin R., Dierks, Elizabeth A., Anderson, Bryan D., Britt, Karen SТом:
51
Мова:
english
Журнал:
Journal of Medicinal Chemistry
DOI:
10.1021/jm701199p
Date:
April, 2008
Файл:
PDF, 424 KB
english, 2008
File converter
Більше результатів пошуку
More benefits 
